trimetazidine has been researched along with mesna in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Arıcı, T; Barut, EN; Engin, S; Kadıoğlu, M; Kerimoğlu, G; Sezen, SF; Soysal, AÇ; Yaşar, YK | 1 |
2 other study(ies) available for trimetazidine and mesna
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Trimetazidine attenuates cyclophosphamide-induced cystitis by inhibiting TLR4-mediated NFκB signaling in mice.
Topics: Animals; Antioxidants; Cyclophosphamide; Cystitis; Inflammation; Mesna; Mice; Mice, Inbred BALB C; NF-kappa B; Toll-Like Receptor 4; Trimetazidine | 2022 |